There were no data relating hPL to maternal metabolic outcomes or fetal parameters in T2DM or PCOS cohorts, or to lipid profiles; and data on maternal obesity and GWG was sparse. The gene discussed is LGALS1; the disease is polycystic ovary syndrome.